Clinical review: extracorporeal blood purification in severe sepsis.
Citations Over TimeTop 10% of 2003 papers
Abstract
Sepsis and septic shock are the leading causes of acute renal failure, multiple organ system dysfunction, and death in the intensive care unit. The pathogenesis of sepsis is complex and comprises a mosaic of interconnected pathways. Several attempts to improve patient outcomes by targeting specific components of this network have been unsuccessful. For these reasons, the ideal immunomodulating strategy would be one that restores immunologic stability rather than blindly inhibiting or stimulating one or another component of this complex network. Hence, the recent focus of immunomodulatory therapy in sepsis has shifted to nonspecific methods of influencing the entire inflammatory response without suppressing it. Here, we discuss the various modalities of extracorporeal blood purification, the existing evidence, and future prospects.
Related Papers
- → [Interpretation on the "surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children"].(2020)
- → Faculty Opinions recommendation of Albumin replacement in patients with severe sepsis or septic shock.(2014)
- → Faculty Opinions recommendation of Soluble MD-2 activity in plasma from patients with severe sepsis and septic shock.(2004)
- → An update on recommendations for the treatment of severe sepsis and septic shock has been released(2008)
- → Faculty Opinions recommendation of Albumin replacement in patients with severe sepsis or septic shock.(2014)